CATALOGO DEI PRODOTTI DELLA RICERCA

GATTI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.129
EU - Europa 16.306
AS - Asia 11.847
SA - Sud America 1.638
Continente sconosciuto - Info sul continente non disponibili 562
AF - Africa 332
OC - Oceania 25
Totale 47.839
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.810
RU - Federazione Russa 5.604
SG - Singapore 4.848
GB - Regno Unito 4.054
CN - Cina 3.451
IT - Italia 1.781
BR - Brasile 1.306
DE - Germania 1.055
HK - Hong Kong 1.007
VN - Vietnam 918
SE - Svezia 867
FR - Francia 856
IE - Irlanda 749
FI - Finlandia 608
KR - Corea 380
BD - Bangladesh 238
IN - India 225
UA - Ucraina 219
JP - Giappone 174
TR - Turchia 157
CA - Canada 152
AR - Argentina 117
NL - Olanda 98
MX - Messico 96
NG - Nigeria 88
IQ - Iraq 78
ID - Indonesia 76
PL - Polonia 75
ZA - Sudafrica 71
ES - Italia 67
EC - Ecuador 53
BE - Belgio 49
CO - Colombia 43
PK - Pakistan 43
AT - Austria 38
UZ - Uzbekistan 36
CL - Cile 35
VE - Venezuela 30
TG - Togo 28
RO - Romania 26
SA - Arabia Saudita 26
BJ - Benin 23
EG - Egitto 23
IR - Iran 22
MA - Marocco 21
LT - Lituania 20
PE - Perù 20
KE - Kenya 19
CH - Svizzera 18
AU - Australia 17
CZ - Repubblica Ceca 17
PH - Filippine 17
PY - Paraguay 14
AE - Emirati Arabi Uniti 13
IL - Israele 13
DZ - Algeria 12
JO - Giordania 12
MY - Malesia 12
PT - Portogallo 12
TN - Tunisia 12
AZ - Azerbaigian 11
CR - Costa Rica 11
JM - Giamaica 11
NP - Nepal 11
AL - Albania 9
BG - Bulgaria 9
BO - Bolivia 9
ET - Etiopia 9
HR - Croazia 9
SK - Slovacchia (Repubblica Slovacca) 9
DO - Repubblica Dominicana 8
GR - Grecia 8
LB - Libano 8
QA - Qatar 8
A2 - ???statistics.table.value.countryCode.A2??? 7
GE - Georgia 7
NZ - Nuova Zelanda 7
PA - Panama 7
RS - Serbia 7
SV - El Salvador 7
UY - Uruguay 7
AM - Armenia 6
DK - Danimarca 6
GT - Guatemala 6
PS - Palestinian Territory 6
SN - Senegal 6
KW - Kuwait 5
LV - Lettonia 5
NO - Norvegia 5
PR - Porto Rico 5
SY - Repubblica araba siriana 5
BS - Bahamas 4
BY - Bielorussia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BW - Botswana 3
EE - Estonia 3
HN - Honduras 3
Totale 47.215
Salva come PNG Salva come JPEG
Città #
Southend 3.616
Singapore 2.563
Ashburn 1.905
Moscow 1.830
Chandler 1.642
San Jose 1.572
Jacksonville 1.490
Dallas 1.391
Hong Kong 980
Woodbridge 787
Dublin 740
Ann Arbor 645
Verona 565
Beijing 543
The Dalles 498
Houston 491
Council Bluffs 387
New York 356
Los Angeles 321
Wilmington 313
Princeton 304
Lawrence 303
Ho Chi Minh City 292
Jinan 254
Nanjing 217
Shenyang 206
Hanoi 202
Bologna 198
Redmond 190
Buffalo 166
Helsinki 161
Tokyo 159
Munich 140
Santa Clara 139
Tianjin 135
Hebei 133
Milan 133
Sindelfingen 123
Redondo Beach 107
São Paulo 107
Columbus 98
Changsha 93
Abuja 86
Zhengzhou 86
Haikou 85
Ningbo 85
Nanchang 82
Orem 75
Hangzhou 72
Taizhou 72
Boardman 71
San Francisco 71
Guangzhou 69
London 65
Warsaw 65
Jiaxing 64
Taiyuan 61
Rome 60
Denver 59
Chicago 57
Falkenstein 57
Turku 57
Seattle 56
Da Nang 48
Montreal 47
Phoenix 47
Washington 47
Brussels 46
Hyderabad 45
Redwood City 45
Atlanta 44
Brooklyn 44
Frankfurt am Main 44
Norwalk 43
Rio de Janeiro 41
Boston 40
Falls Church 40
Toronto 39
Johannesburg 38
Fairfield 37
Jakarta 36
Brasília 35
Mexico City 35
Tashkent 34
Fuzhou 33
Lanzhou 33
Stockholm 33
Chennai 32
Belo Horizonte 31
Detroit 31
Poplar 31
Düsseldorf 30
Manchester 30
Biên Hòa 29
Haiphong 28
Lomé 28
Seoul 28
Amsterdam 27
Dearborn 26
Lancaster 26
Totale 29.301
Salva come PNG Salva come JPEG
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 351
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 272
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 269
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 266
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 256
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 256
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 246
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 245
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 244
Anti-CCP antibodies and bone 244
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 240
[Therapeutic strategies in osteoporosis: whom and when to treat] 233
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 232
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 230
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 228
Bone metabolism in patients with anorexia nervosa and amenorrhoea 228
[Risk factors for hip fracture in elderly persons]. 224
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 224
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 223
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 217
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 215
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 215
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 211
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 210
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 209
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 209
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 207
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 207
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 206
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 205
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 204
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 204
Bone involvement and osteoporosis in mastocytosis. 203
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 203
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 198
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 198
Prevalence and incidence of rheumatoid arthritis in Italy. 191
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 191
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 191
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 190
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 188
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 188
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 188
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 188
Could γ\δ T-cells explain zoledronic acid adverse events? 187
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 187
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 185
Association between bone mineral density and serum lipid in men 184
[Antinflammatory therapy and cardiovascular risk: a consensus view]. 184
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 184
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 182
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 182
Guidelines for the diagnosis, prevention and management of osteoporosis 181
The obesity paradox and osteoporosis 180
Allergy and the bone: unexpected relationships 179
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 179
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 179
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 178
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 178
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 176
Osteoporosis treatment: why ibandronic acid? 175
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 174
Rapporti tra sistema immune e metabolismo osseo 174
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 173
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 172
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 172
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 172
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 171
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 170
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 170
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 169
DXA bone mineral density in males: retrospective study in real life. 167
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 167
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 166
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women 165
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 165
Sclerostin and DKK1 in primary hyperparathyroidism. 165
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 165
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 165
Association between environmental air pollution and rheumatoid arthritis flares 164
Effects of denosumab on peripheral lymphocyte subpopulations 163
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 162
Artropatie degenerative 162
Coxibs: a significant therapeutic opportunity. 162
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 162
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 162
GH in combination with bisphosphonate treatment in osteogenesis imperfecta 161
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 161
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 160
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 160
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 159
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 159
Association between acute exposure to environmental air pollution and fragility hip fractures 157
Prevalence of osteoporosis in patients affected by mastocytosis 157
Safety issues and adverse reactions with osteoporosis management 157
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 156
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 156
Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis 156
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 155
Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes 155
Totale 19.215
Salva come PNG Salva come JPEG
Categoria #
all - tutte 168.952
article - articoli 163.960
book - libri 0
conference - conferenze 682
curatela - curatele 0
other - altro 291
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.019
Totale 337.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.168 0 608 27 111 119 113 37 130 169 65 196 593
2022/20234.908 372 430 477 889 434 1.180 55 262 535 46 167 61
2023/20242.537 106 207 229 306 306 415 111 184 43 100 364 166
2024/20256.683 358 448 296 1.026 347 198 306 298 999 579 533 1.295
2025/202619.356 1.371 996 1.473 3.206 4.687 1.298 1.925 1.103 1.369 957 366 605
2026/2027357 312 45 0 0 0 0 0 0 0 0 0 0
Totale 47.839